LSB Industries, Inc. Reports Operating Results for the 2023 First Quarter
First Quarter 2023 Highlights
-
Net sales of
$181 million compared to$199 million in the first quarter of 2022 -
Net income of
$16 million compared to$59 million in the first quarter of 2022; Adjusted net income of$19 million as compared to$62 million in the first quarter of 2022 -
EPS of
$0.21 compared to$0.66 for the first quarter of 2022; Adjusted EPS(1) of$0.25 compared to$0.69 in the first quarter of 2022 -
Adjusted EBITDA(1) of
$51 million compared to$101 million in the first quarter of 2022 -
Cash Flow from Operations of
$59 million and Capital Expenditures of$18 million -
Total cash and short-term investments of approximately
$426 million as ofMarch 31, 2023 -
Trailing twelve-month total recordable injury rate of 0.87 as of
March 31, 2023 - Achieved a milestone in our El Dorado CCS project by filing a Class VI sequestration well permit
(1) | This is a Non-GAAP measure. Refer to the Non-GAAP Reconciliation section. |
First Quarter Results Overview |
||||||||||||
|
|
Three Months Ended
|
|
|||||||||
Product (Gross Sales in |
|
2023 |
|
|
2022 |
|
|
% Change |
|
|||
AN & Nitric Acid |
|
$ |
58,272 |
|
|
$ |
71,800 |
|
|
|
(19 |
)% |
Urea ammonium nitrate (UAN) |
|
|
46,590 |
|
|
|
56,569 |
|
|
|
(18 |
)% |
Ammonia |
|
|
63,415 |
|
|
|
59,342 |
|
|
|
7 |
% |
Other |
|
|
12,687 |
|
|
|
11,270 |
|
|
|
13 |
% |
Total |
|
$ |
180,964 |
|
|
$ |
198,981 |
|
|
|
(9 |
)% |
Comparison of 2023 to 2022 quarterly periods:
-
Net sales declined during the quarter driven by lower pricing for all of our products and the impact of extremely cold weather that caused the
Cherokee facility to be down for the first half of January. The headwind of lower pricing andCherokee downtime was partially offset by higher sales volumes for ammonia and UAN. - The year-over-year decline in operating income and adjusted EBITDA primarily resulted from lower selling prices and higher natural gas feedstock prices, partially offset by higher sales volumes.
The following tables provide key sales metrics for our products:
|
|
Three Months Ended
|
|
||||||||||
Key Product Volumes (short tons sold) |
|
2023 |
|
2022 |
|
|
% Change |
|
|||||
AN & Nitric Acid |
|
122,745 |
|
|
144,517 |
|
|
(15 |
)% |
||||
Urea ammonium nitrate (UAN) |
|
113,026 |
|
|
100,153 |
|
|
13 |
% |
||||
Ammonia |
|
88,997 |
|
|
60,725 |
|
|
47 |
% |
||||
|
|
324,768 |
|
|
305,395 |
|
|
6 |
% |
||||
Average Selling Prices (price per short ton) (A) |
|
|
|
|
|
|
|||||||
AN & Nitric Acid |
$ |
417 |
|
$ |
438 |
|
|
(5 |
)% |
||||
Urea ammonium nitrate (UAN) |
$ |
379 |
|
$ |
553 |
|
|
(31 |
)% |
||||
Ammonia |
$ |
703 |
|
$ |
961 |
|
|
(27 |
)% |
(A) Average selling prices represent “net back” prices which are calculated as sales less freight expenses divided by product sales volume in tons. |
|
|
Three Months Ended
|
|
|||||||||
|
|
2023 |
|
|
2022 |
|
|
% Change |
|
|||
Average Benchmark Prices (price per ton) |
|
|
|
|
|
|
|
|
|
|||
Tampa Ammonia (MT) Benchmark |
|
$ |
728 |
|
|
$ |
1,206 |
|
|
|
(40 |
)% |
NOLA UAN |
|
$ |
318 |
|
|
$ |
569 |
|
|
|
(44 |
)% |
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Input Costs |
|
|
|
|
|
|
|
|
|
|||
Average natural gas cost/MMBtu |
|
$ |
5.66 |
|
|
$ |
4.74 |
|
|
|
19 |
% |
Financial Position and Capital Expenditures
As of
Interest expense for the first quarter of 2023 was
Capital expenditures were approximately
Market Outlook
Nitrogen fertilizer prices moderated in recent months, largely reflecting a decline in European production costs. Natural gas prices in
In addition to the lower production costs for European producers as compared to a year ago, the decline in fertilizer prices reflects the impact of a delay in this season's spring fertilizer application in many corn growing regions of the
Our industrial business has been robust and demand for our products is steady. Nitric acid demand is stable as the demand impacts of high inflation in the
Conference Call
LSB’s management will host a conference call covering the first quarter results on
To listen to a webcast of the call, please go to the Company’s website at www.lsbindustries.com at least 15 minutes prior to the conference call to download and install any necessary audio software. If you are unable to listen live, the conference call webcast will be archived on the Company’s website.
Forward-Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake no obligation to update or revise any forward-looking statements, whether because of new information or future developments.
See Accompanying Tables
|
||||||||
Condensed Consolidated Statements of Operations |
||||||||
(Unaudited) |
||||||||
|
||||||||
|
|
Three Months Ended |
|
|||||
|
|
|
|
|||||
|
|
2023 |
|
|
2022 |
|
||
|
|
(In Thousands, Except Per Share Amounts) |
|
|||||
Net sales |
|
$ |
180,964 |
|
|
$ |
198,981 |
|
Cost of sales |
|
|
139,359 |
|
|
|
108,251 |
|
Gross profit |
|
|
41,605 |
|
|
|
90,730 |
|
|
|
|
|
|
|
|
||
Selling, general and administrative expense |
|
|
9,867 |
|
|
|
10,935 |
|
Other expense (income), net |
|
|
1,203 |
|
|
|
(176 |
) |
Operating income |
|
|
30,535 |
|
|
|
79,971 |
|
|
|
|
|
|
|
|
||
Interest expense, net |
|
|
12,212 |
|
|
|
9,955 |
|
Non-operating other expense (income), net |
|
|
(3,476 |
) |
|
|
135 |
|
Income before provision for income taxes |
|
|
21,799 |
|
|
|
69,881 |
|
Provision for income taxes |
|
|
5,898 |
|
|
|
11,115 |
|
Net income |
|
|
15,901 |
|
|
|
58,766 |
|
|
|
|
|
|
|
|
||
Income per common share: |
|
|
|
|
|
|
||
Basic: |
|
|
|
|
|
|
||
Net income |
|
$ |
0.21 |
|
|
$ |
0.66 |
|
|
|
|
|
|
|
|
||
Diluted: |
|
|
|
|
|
|
||
Net income |
|
$ |
0.21 |
|
|
$ |
0.65 |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Adjusted Net Income and Adjusted EPS(1) |
|
|
|
|
|
|
||
Net income |
|
$ |
15,901 |
|
|
$ |
58,766 |
|
Adjustments |
|
|
2,876 |
|
|
|
3,630 |
|
Adjusted net income |
|
$ |
18,777 |
|
|
$ |
62,396 |
|
|
|
|
|
|
|
|
||
Net income per common share, excluding adjustments |
|
$ |
0.25 |
|
|
$ |
0.69 |
|
(1) |
This is a Non-GAAP measure. Refer to the Non-GAAP Reconciliation section. |
|
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(Information at |
||||||||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
|
|
(In Thousands) |
|
|||||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
48,949 |
|
|
$ |
63,769 |
|
Short-term investments |
|
|
376,882 |
|
|
|
330,553 |
|
Accounts receivable |
|
|
60,251 |
|
|
|
75,494 |
|
Allowance for doubtful accounts |
|
|
(693 |
) |
|
|
(699 |
) |
Accounts receivable, net |
|
|
59,558 |
|
|
|
74,795 |
|
Inventories: |
|
|
|
|
|
|
||
Finished goods |
|
|
28,102 |
|
|
|
28,893 |
|
Raw materials |
|
|
1,530 |
|
|
|
1,990 |
|
Total inventories |
|
|
29,632 |
|
|
|
30,883 |
|
Supplies, prepaid items and other: |
|
|
|
|
|
|
||
Prepaid insurance |
|
|
12,271 |
|
|
|
17,429 |
|
Precious metals |
|
|
14,474 |
|
|
|
13,323 |
|
Supplies |
|
|
28,570 |
|
|
|
27,501 |
|
Other |
|
|
9,491 |
|
|
|
8,346 |
|
Total supplies, prepaid items and other |
|
|
64,806 |
|
|
|
66,599 |
|
Total current assets |
|
|
579,827 |
|
|
|
566,599 |
|
|
|
|
|
|
|
|
||
Property, plant and equipment, net |
|
|
842,925 |
|
|
|
848,661 |
|
|
|
|
|
|
|
|
||
Other assets: |
|
|
|
|
|
|
||
Operating lease assets |
|
|
21,321 |
|
|
|
22,682 |
|
Intangible and other assets, net |
|
|
1,697 |
|
|
|
1,877 |
|
|
|
|
23,018 |
|
|
|
24,559 |
|
|
|
|
|
|
|
|
||
|
|
$ |
1,445,770 |
|
|
$ |
1,439,819 |
|
|
||||||||
Condensed Consolidated Balance Sheets (continued) |
||||||||
(Information at |
||||||||
|
||||||||
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
|
|
(In Thousands) |
|
|||||
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
68,341 |
|
|
$ |
78,182 |
|
Short-term financing |
|
|
10,168 |
|
|
|
16,134 |
|
Accrued and other liabilities |
|
|
43,617 |
|
|
|
38,470 |
|
Current portion of long-term debt |
|
|
8,544 |
|
|
|
9,522 |
|
Total current liabilities |
|
|
130,670 |
|
|
|
142,308 |
|
|
|
|
|
|
|
|
||
Long-term debt, net |
|
|
702,071 |
|
|
|
702,733 |
|
|
|
|
|
|
|
|
||
Noncurrent operating lease liabilities |
|
|
13,460 |
|
|
|
14,896 |
|
|
|
|
|
|
|
|
||
Other noncurrent accrued and other liabilities |
|
|
522 |
|
|
|
522 |
|
|
|
|
|
|
|
|
||
Deferred income taxes |
|
|
69,095 |
|
|
|
63,487 |
|
|
|
|
|
|
|
|
||
Commitments and contingencies |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Stockholders' equity: |
|
|
|
|
|
|
||
Common stock, |
|
|
9,117 |
|
|
|
9,117 |
|
Capital in excess of par value |
|
|
497,216 |
|
|
|
497,179 |
|
Retained earnings |
|
|
214,993 |
|
|
|
199,092 |
|
|
|
|
721,326 |
|
|
|
705,388 |
|
Less treasury stock, at cost: |
|
|
|
|
|
|
||
Common stock, 15.0 million shares (14.9 million shares at |
|
|
191,374 |
|
|
|
189,515 |
|
Total stockholders' equity |
|
|
529,952 |
|
|
|
515,873 |
|
|
|
$ |
1,445,770 |
|
|
$ |
1,439,819 |
|
Non-GAAP Reconciliations
This news release includes certain “non-GAAP financial measures” under the rules of the
EBITDA and Adjusted EBITDA Reconciliation
EBITDA is defined as net income (loss) plus interest expense and interest income, net, less gain on extinguishment of debt, plus depreciation and amortization (D&A) (which includes D&A of property, plant and equipment and amortization of intangible and other assets), plus provision (benefit) for income taxes. Adjusted EBITDA is reported to show the impact of non-cash stock-based compensation, one time/non-cash or non-operating items-such as, one-time income or fees, loss (gain) on sale of a business and/or other property and equipment, certain fair market value (FMV) adjustments, and consulting costs associated with reliability and purchasing initiatives (Initiatives). We historically have performed turnaround activities on an annual basis; however, we have moved towards extending turnarounds to a two or three-year cycle. Rather than being capitalized and amortized over the period of benefit, our accounting policy is to recognize the costs as incurred. Given these turnarounds are essentially investments that provide benefits over multiple years, they are not reflective of our operating performance in a given year.
We believe that certain investors consider EBITDA a useful means of measuring our ability to meet our debt service obligations and evaluating our financial performance. In addition, we believe that certain investors consider adjusted EBITDA as more meaningful to further assess our performance. We believe that the inclusion of supplementary adjustments to EBITDA is appropriate to provide additional information to investors about certain items.
EBITDA and adjusted EBITDA have limitations and should not be considered in isolation or as a substitute for net income, operating income, cash flow from operations or other consolidated income or cash flow data prepared in accordance with GAAP. Because not all companies use identical calculations, this presentation of EBITDA and adjusted EBITDA may not be comparable to a similarly titled measure of other companies. The following table provides a reconciliation of net income (loss) to EBITDA and adjusted EBITDA for the periods indicated. Adjusted EBITDA margin is calculated by taking adjusted EBITDA divided by
|
||||||||
Non-GAAP Reconciliations (continued) |
||||||||
|
||||||||
LSB Consolidated ($ In Thousands) |
|
Three Months Ended
|
|
|||||
|
|
2023 |
|
|
2022 |
|
||
Net income |
|
$ |
15,901 |
|
|
$ |
58,766 |
|
Plus: |
|
|
|
|
|
|
||
Interest expense and interest income, net |
|
|
8,731 |
|
|
|
9,955 |
|
Net loss on extinguishments of debt |
|
|
— |
|
|
|
113 |
|
Depreciation and amortization |
|
|
17,604 |
|
|
|
17,507 |
|
Provision for income taxes |
|
|
5,898 |
|
|
|
11,115 |
|
EBITDA |
|
$ |
48,134 |
|
|
$ |
97,456 |
|
|
|
|
|
|
|
|
||
Stock-based compensation |
|
|
719 |
|
|
|
803 |
|
Legal fees (Leidos) |
|
|
273 |
|
|
|
342 |
|
Loss (gain) on disposal of assets |
|
|
1,890 |
|
|
|
(46 |
) |
Turnaround costs |
|
|
(6 |
) |
|
|
2,531 |
|
Adjusted EBITDA |
|
$ |
51,010 |
|
|
$ |
101,086 |
|
|
||||||||
Non-GAAP Reconciliations (continued) |
||||||||
(in thousands, except per share amounts) |
||||||||
|
||||||||
|
|
Three Months Ended |
|
|||||
|
|
|
|
|||||
|
|
2023 |
|
|
2022 |
|
||
Numerator: |
|
|
|
|
|
|
||
Net income |
|
$ |
15,901 |
|
|
$ |
58,766 |
|
Adjustments: |
|
|
|
|
|
|
||
Stock-based compensation |
|
|
719 |
|
|
|
803 |
|
Legal fees (Leidos) |
|
|
273 |
|
|
|
342 |
|
Loss (gain) on disposal of assets |
|
|
1,890 |
|
|
|
(46 |
) |
Turnaround costs |
|
|
(6 |
) |
|
|
2,531 |
|
Net income, excluding adjustments |
|
$ |
18,777 |
|
|
$ |
62,396 |
|
Denominator: |
|
|
|
|
|
|
||
Adjusted weighted-average shares for basic net income
|
|
|
75,807 |
|
|
|
88,421 |
|
Adjustment: |
|
|
|
|
|
|
||
Unweighted shares, including unvested restricted
|
|
|
409 |
|
|
|
1,691 |
|
Outstanding shares, net of treasury, at period
|
|
|
76,216 |
|
|
|
90,112 |
|
|
|
|
|
|
|
|
||
Basic net income per common share |
|
$ |
0.21 |
|
|
$ |
0.66 |
|
|
|
|
|
|
|
|
||
Net income per common share,
|
|
$ |
0.25 |
|
|
$ |
0.69 |
|
|
|
|
|
|
|
|
(1) Excludes the weighted-average shares of unvested restricted stock that are subject to forfeiture |
Ammonia, AN, Nitric Acid, UAN Sales Price Reconciliation
The following table provides a reconciliation of total identified net sales as reported under GAAP in our consolidated financial statements reconciled to netback sales which is calculated as net sales less freight and other non-netback costs. We believe this provides a relevant industry comparison among our peer group.
|
|
Three Months Ended
|
|
|||||
|
|
2023 |
|
|
2022 |
|
||
|
|
(In Thousands) |
|
|||||
Ammonia, AN, Nitric Acid, UAN net sales |
|
$ |
168,277 |
|
|
$ |
187,712 |
|
|
|
|
|
|
|
|
||
Less freight and other |
|
|
11,754 |
|
|
|
10,609 |
|
|
|
|
|
|
|
|
||
Ammonia, AN, Nitric Acid, UAN netback sales |
|
$ |
156,523 |
|
|
$ |
177,103 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230502006088/en/
(405) 510-3524
(405) 510-3550
fbuonocore@lsbindustries.com
Source: